Related Experiment Video
Updated: Jun 22, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes
Scott Baker1, George Jerums, Joseph Proietto
1Department of Medicine, Austin Health, University of Melbourne, Heidelberg Repatriation Hospital, 300 Waterdale Road, West Heidelberg, VIC 3081, Australia. scott.baker@austin.org.au
Abstract:
A recent study has shown that obese patients with newly diagnosed type 2 diabetes who lose 10% of their body weight are more likely to achieve glycaemic and blood pressure targets, despite weight regain. A well-established non-surgical method for achieving weight loss >or=10% within 3 months is the use of very-low-calorie diets (VLCDs). In patients with diabetes, VLCDs are associated with rapid improvement in glycaemia and cardiovascular risk factors. The present review analyses the evidence from available trials on the effects of VLCDs on body weight, glycaemic control and complications, and their potential for clinical use in diabetes management.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes I: Introduction
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational